Cover Image

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer

Objectives: To evaluate the impact of bowel resection at the time of interval cytoreductive surgery on survival. Methods: We identified patients with advanced ovarian cancer who underwent neoadjuvant chemotherapy and interval cytoreductive surgery between 2008 and 2018 from a single-institution tumo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Blair McNamara (Author), Rosa Guerra (Author), Jennifer Qin (Author), Amaranta D. Craig (Author), Lee-may Chen (Author), Madhulika G. Varma (Author), Jocelyn S. Chapman (Author)
Format:	Book
Published:	Elsevier, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary cytoreductive surgery or interval cytoreductive surgery
by: Yiu-Tai Li, et al.
Published: (2024)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
by: Soo Young Jeong, et al.
Published: (2019)

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
by: Semiramis L. Carbajal-Mamani, et al.
Published: (2020)

Right upper quadrant cytoreductive procedures and cardiophrenic lymph node resection in primary debulkig surgery for ovarian cancer
by: Joao Casanova, et al.
Published: (2021)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
by: Amelia M. Jernigan, et al.
Published: (2013)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
by: Eleonora Ghisoni, et al.
Published: (2018)

Cholecystectomy at the time of open cytoreductive surgery for ovarian cancer
by: Lindsey Finch, et al.
Published: (2024)

Advances in Cytoreductive Surgery and Combination Therapy for Ovarian Cancer
by: Xiaolan Lv, et al.
Published: (2022)

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
by: Mitchell Clark, et al.
Published: (2021)

Challenges of cytoreduction in porta hepatis in surgery for advanced ovarian cancer
by: Kvvn Raju, et al.
Published: (2024)

Predicting the outcome of cytoreductive surgery in patients with advanced ovarian cancer
by: M. G. Yakovleva, et al.
Published: (2023)

Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
by: Guanchen Ma, et al.
Published: (2023)

The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis
by: Ting Ding, et al.
Published: (2021)

CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
by: Wang Fang, et al.
Published: (2013)

The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
by: Dana M. Chase, et al.
Published: (2024)

Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department's experience)
by: N. G. Kormosh, et al.
Published: (2014)

En-block cytoreduction for advanced ovarian cancer
by: Anastasios Pandraklakis, et al.
Published: (2023)

Optimal cytoreduction for advanced epithelial ovarian cancer
by: N. G. Kormosh, et al.
Published: (2014)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024)

Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer
by: Susan Addley, et al.
Published: (2021)

Postoperative chest liver herniation after cardiophrenic lymph node resection by a transdiaphragmatic approach following primary cytoreductive surgery for advanced endometrioid ovarian cancer: A case report
by: Hélène Leray, et al.
Published: (2021)

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020)

Laparoscopy and computed tomography imaging in advanced ovarian tumors: A roadmap for prediction of optimal cytoreductive surgery
by: Ahmed Samy El-Agwany
Published: (2018)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019)

Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
by: Elham Saffarieh, et al.
Published: (2022)

Predictors of Intensive Care Unit Admission Following Cytoreductive Surgery For Stage III-IV Ovarian Carcinoma
by: Cafer Kaplan, et al.
Published: (2012)

Network of Mediators for Vascular Inflammation and Leakage Is Dysbalanced during Cytoreductive Surgery for Late-Stage Ovarian Cancer
by: Sven Klaschik, et al.
Published: (2019)

Bowel resection in Nigerian children
by: Abdur-Rahman L, et al.
Published: (2009)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
by: Wei Chen, et al.
Published: (2021)

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery
by: Abigail S. Zamorano, et al.
Published: (2022)

Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models
by: Alexandros Laios, et al.
Published: (2020)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019)

Primary diaphragmatic closure following diaphragmatic resection and cardiophrenic lymph node dissection during interval debulking surgery for advanced ovarian malignancy
by: Susan Addley, et al.
Published: (2021)

Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India
by: Priya Bhati, et al.
Published: (2024)

Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis
by: Kristin S. Weeks, et al.
Published: (2020)

When we open and close: Postoperative outcomes after aborted primary cytoreduction for ovarian cancer
by: Connor C. Wang, et al.
Published: (2022)

Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
by: Joy M. Beissel, et al.
Published: (2014)

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials
by: Changchun Jian, et al.
Published: (2023)

Predictive Factors for Bowel Resection in Childhood Intussusception
by: Idrissa Salahoudine, et al.
Published: (2024)

Fatal cardiac tamponade following cytoreductive surgery for serous carcinoma of the ovary
by: Emily English, et al.
Published: (2015)